PMC:7195088 / 28777-28932 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T146","span":{"begin":114,"end":122},"obj":"Disease"}],"attributes":[{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"p 3 weeks).\n• Comparison of lopinavir/ritonavir vs. hydroxychloroquine vs. losartan vs. placebos in patients with COVID-19. Double-blind, adaptive RCT (NCT"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T378","span":{"begin":28,"end":47},"obj":"Chemical"},{"id":"T379","span":{"begin":28,"end":37},"obj":"Chemical"},{"id":"T380","span":{"begin":38,"end":47},"obj":"Chemical"},{"id":"T381","span":{"begin":52,"end":70},"obj":"Chemical"},{"id":"T382","span":{"begin":75,"end":83},"obj":"Chemical"}],"attributes":[{"id":"A378","pred":"chebi_id","subj":"T378","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A379","pred":"chebi_id","subj":"T379","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A380","pred":"chebi_id","subj":"T380","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A381","pred":"chebi_id","subj":"T381","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A382","pred":"chebi_id","subj":"T382","obj":"http://purl.obolibrary.org/obo/CHEBI_6541"}],"text":"p 3 weeks).\n• Comparison of lopinavir/ritonavir vs. hydroxychloroquine vs. losartan vs. placebos in patients with COVID-19. Double-blind, adaptive RCT (NCT"}

{"project":"LitCovid-sentences","denotations":[{"id":"T220","span":{"begin":12,"end":123},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"p 3 weeks).\n• Comparison of lopinavir/ritonavir vs. hydroxychloroquine vs. losartan vs. placebos in patients with COVID-19. Double-blind, adaptive RCT (NCT"}